SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event
reported): May 21, 2018
XSPAND PRODUCTS LAB, INC.
(Exact Name of Registrant as Specified in
|(State or other jurisdiction
4030 Skyron Drive,
|(Address of principal executive offices)
|(Registrant’s Telephone Number, Including Area Code)|
(Former name or former address, if changed
since last report)
Marc J. Adesso
Waller Lansden Dortch & Davis, LLP
511 Union Street, Suite 2700
Nashville, Tennessee 37219
Telephone: (615) 244-6380
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|¨||Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
|¨||Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
|¨||Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|¨||Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. x
||Results of Operations and Financial Condition.|
On May 21, 2018, Xspand
Products Lab, Inc. (the “Company”) issued a press release announcing its financial performance for the first fiscal
quarter ended March 31, 2018, as well as discussing other recent corporate developments. A copy of the press release is furnished
herewith as Exhibit 99.1.
|Item 7.01.||Regulation FD Disclosure.
On May 23, 2018, the
Company issued a press release announcing its entrance into a two-year manufacturing agreement with a leading children’s
sleep products brand. A copy of the press release is furnished herewith as Exhibit 99.2.
The information contained
in this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of
1933, as amended or the Exchange Act, except as shall be expressly set forth by specific reference
in such a filing. The furnishing of the information in this Current Report on Form 8-K is not intended to, and does not, constitute
a representation that such furnishing is required by Regulation FD or that the information contained in this Current Report on
Form 8-K constitutes material investor information that is not otherwise publicly available.
The Securities and
Exchange Commission encourages registrants to disclose forward-looking information so that investors can better understand the
future prospects of a registrant and make informed investment decisions. This Current Report on Form 8-K and exhibits may contain
these types of statements, which are “forward-looking statements” within the meaning of the Private Securities Litigation
Reform Act of 1995, and which involve risks, uncertainties and reflect the Company’s judgment as of the date of this Current
Report on Form 8-K. Forward-looking statements may relate to, among other things, operating results and are indicated by words
or phrases such as “expects,” “should,” “will,” and similar words or phrases. These statements
are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at
the date of this Current Report on Form 8-K. Investors are cautioned not to rely unduly on forward-looking statements when evaluating
the information presented within.
|Item 9.01.||Financial Statements and Exhibits.
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: May 24, 2017
||XSPAND PRODUCTS LAB, INC.
||/s/ Christopher B. Ferguson
||Christopher B. Ferguson
||Chief Executive Officer